NCT01720862

Brief Summary

This research is being done to look at the association between migraine and obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2012

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2012

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 31, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 2, 2012

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

January 28, 2016

Status Verified

January 1, 2016

Enrollment Period

3.5 years

First QC Date

October 31, 2012

Last Update Submit

January 27, 2016

Conditions

Keywords

migraineepisodic migrainechronic migraineobesitynon-obese

Outcome Measures

Primary Outcomes (1)

  • association between migraine and obesity - evaluate serum adipokine levels

    The first aim of the proposed research is to evaluate serum adipokine levels in a clinical cohort of obese and non-obese episodic and chronic migraineurs and examine their utility as markers of the presence or absence of migraine and their relationship to headache frequency.

    5 years

Secondary Outcomes (1)

  • association between migraine and obesity -evaluate subcutaneous adipose tissue (SAT) and its ratio to visceral adipose tissue (VAT)

    five years

Study Arms (3)

Episodic migraineurs

Those with migraines \>2 and \< 12 times per month.

Chronic migraineurs

Those with migraines greater than 14 days per month.

Controls

Those without headaches other than occasional hangover, cold, flu headaches.

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Premenopausal Caucasian women ages 18-55 years with or without migraine.

You may qualify if:

  • Premenopausal women (18-55 years)
  • Normal weight (BMI = 18.5 - 24.9) or obese (BMI ≥ 30)
  • Diagnosis of episodic or chronic migraine or pain free control

You may not qualify if:

  • Evidence of pain disorder other than migraine (e.g. irritable bowel syndrome)
  • Chronic conditions known to alter risk or pattern of migraine (e.g. hypothyroidism)
  • Illnesses that may affect adipokine levels (e.g. diabetes)
  • Clinically relevant abnormal glucose/cholesterol levels
  • Pregnant women
  • Potential participants who are unable to undergo MRI based on standard screening questionnaire (those with brain aneurysm or surgical clips, certain types of artificial heart valves, heart defibrillator or pacemaker, cochlear implants, eye implants, blood vessel coil, recently placed artificial joints, certain types of vascular stents, history of bullets, pellets, BBs, history of any implanted metal or device or who have worked with sheet metal in the past)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Johns Hopkins Bayview Headache Center

Baltimore, Maryland, 21224, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

serum

MeSH Terms

Conditions

Migraine DisordersObesity

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Barbara L Peterlin, DO

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Headache Research, Johns Hopkins Bayview

Study Record Dates

First Submitted

October 31, 2012

First Posted

November 2, 2012

Study Start

April 1, 2012

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

January 28, 2016

Record last verified: 2016-01

Locations